Cellular Therapy Tracking Market Report 2026

Cellular Therapy Tracking Market Overview

• Cellular Therapy Tracking market size has reached to $2.9 billion in 2025 • Expected to grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Increasing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Enhancing Need For Patient-Specific Cell Monitoring And Regulatory Compliance • Market Trend: Scalable Platforms Ensure Cell Traceability And Patient Safety • North America was the largest region in 2025.

What Is Covered Under Cellular Therapy Tracking Market?

Cellular therapy tracking refers to the systematic process of monitoring and managing the entire lifecycle of cellular therapies from cell collection and manufacturing to distribution, administration, and long-term patient outcomes. It ensures product integrity, regulatory compliance, patient safety, and treatment effectiveness through detailed data capture and traceability. It also helps optimize workflow efficiency and maintain accurate documentation throughout the therapy process. The main product types of cellular therapy tracking are software and services. The software provides digital platforms and tools to manage, monitor, and organize data related to cell therapy operations and processes. It is used for various applications, including cancer, cardiovascular diseases, musculoskeletal disorders, and others, serving end users such as hospitals, research institutes, biotechnology companies, and others.

What Is The Cellular Therapy Tracking Market Growth Forecast?

The cellular therapy tracking market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing commercialization of cell and gene therapies, rising demand for real-time therapy visibility, expansion of decentralized clinical trials, growing focus on patient safety and compliance, increased investment in digital health infrastructure. Major trends in the forecast period include increasing adoption of end-to-end therapy traceability platforms, growing integration of compliance and reporting software, rising use of real-time supply chain monitoring, expansion of data-driven workflow optimization tools, enhanced focus on regulatory transparency.

Global Cellular Therapy Tracking Market Segmentation

1) By Product Type: Software, Services 2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications 3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users Subsegments: 1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools 2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services

What Is The Driver Of The Cellular Therapy Tracking Market?

The increasing adoption of personalized medicine is expected to drive the growth of the cellular therapy tracking market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Cellular therapy tracking supports personalized medicine by ensuring accurate monitoring and management of patient-specific cells throughout the therapy process. It enhances treatment safety and efficacy by providing end-to-end traceability, regulatory compliance, and streamlined workflow for healthcare providers. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the cellular therapy tracking industry.

Key Players In The Global Cellular Therapy Tracking Market

Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., TrakCel

Global Cellular Therapy Tracking Market Trends and Insights

Major companies operating in the cellular therapy tracking market are focusing on developing scalable platforms, such as chain of identity (COI) management platforms, to ensure cell traceability, regulatory compliance, and patient safety. Chain of identity (COI) management platforms refer to digital systems that track and verify the identity of patient-specific cells throughout the entire cellular therapy process, ensuring traceability and patient safety. For instance, in May 2023, TrakCel Limited, a UK-based software company, launched OCELLOS Core, a new addition to its OCELLOS suite, designed as a Chain of Identity (COI) management platform for early-stage autologous and personalized cell and gene therapy (CGT) clinical trials. It provides automated COI tracking, ensuring accurate patient records from the first enrollment. The pre-configured, validated system can be deployed within 2–3 weeks, offering cost-effective scalability as therapies progress from trials to commercialization. It also tracks the chain of custody events with full audit trails, enhancing compliance and collaboration.

What Are Latest Mergers And Acquisitions In The Cellular Therapy Tracking Market?

In June 2025, STEMCELL Technologies Inc., a Canada-based biotechnology company, acquired Cellular Highways Ltd. for an undisclosed amount. With this acquisition, STEMCELL Technologies aims to integrate Cellular Highways’ advanced cell sorting technology into its portfolio, enhancing the efficiency, scalability, and precision of cellular therapy manufacturing and tracking. Cellular Highways Ltd. is a UK-based biotechnology company that specializes in advanced cell sorting technologies for cellular therapy tracking.

Regional Outlook

North America was the largest region in the cellular therapy tracking market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cellular Therapy Tracking Market?

The cellular therapy tracking market includes revenues earned by entities through logistics management, temperature-controlled shipping, chain of custody compliance, consulting and advisory support, cryopreservation, secure biostorage, end-to-end supply chain solutions, and quality assurance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cellular Therapy Tracking Market Report 2026?

The cellular therapy tracking market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cellular therapy tracking industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.